Abiopharma

Precigen Announces Up to $125 Million Non-Dilutive Financing

Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary

Fractyl Health Expands Board of Directors with Appointments of Industry Leaders to Advance Clinical Execution and Strategic Growth

MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Breckenridge Distillery Expands California Distribution with Winebow

TScan Therapeutics to Participate in Upcoming Investor Conferences

SINTX Technologies Publishes Landmark Study Demonstrating Broad-Spectrum Antiviral Activity of Silicon Nitride

Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

C4 Therapeutics to Present Data from the Phase 1 Trial of Cemsidomide in Multiple Myeloma at the International Myeloma Society (IMS) Annual Meeting

New Form 6-K - GSK plc Filed: 2025-09-03 AccNo: 0001654954-25-010336 Size: 2 MB

New Form 8-K - Chemours Co Filed: 2025-09-03 AccNo: 0000950170-25-112670 Size: 247 KB Item 8.01: Other Events

Chemours Announces Board Leadership Appointments: Mary Cranston Named Chair, Alister Cowan Named Lead Independent Director

New Form 6-K - Haleon plc Filed: 2025-09-03 AccNo: 0001654954-25-010334 Size: 37 KB

Grey symbol attribute type Security_Name was changed. Previous value: NTT DC REIT MANAGER REIT. New value: ONTRAK INC 9.50% A PFD.

General Announcement: ANNOUNCEMENT ON CONVENING AN ONLINE CONFERENCE